Aurinia Pharmaceuticals Statistics
Total Valuation
AUPH has a market cap or net worth of $2.06 billion. The enterprise value is $1.79 billion.
| Market Cap | 2.06B |
| Enterprise Value | 1.79B |
Important Dates
The last earnings date was Tuesday, November 4, 2025, before market open.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AUPH has 131.84 million shares outstanding. The number of shares has decreased by -1.24% in one year.
| Current Share Class | 131.84M |
| Shares Outstanding | 131.84M |
| Shares Change (YoY) | -1.24% |
| Shares Change (QoQ) | -1.10% |
| Owned by Insiders (%) | 1.87% |
| Owned by Institutions (%) | 54.46% |
| Float | 128.25M |
Valuation Ratios
The trailing PE ratio is 28.39 and the forward PE ratio is 19.28.
| PE Ratio | 28.39 |
| Forward PE | 19.28 |
| PS Ratio | 8.05 |
| Forward PS | 6.78 |
| PB Ratio | 5.63 |
| P/TBV Ratio | 5.69 |
| P/FCF Ratio | 17.21 |
| P/OCF Ratio | 17.15 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.76, with an EV/FCF ratio of 14.93.
| EV / Earnings | 22.95 |
| EV / Sales | 6.72 |
| EV / EBITDA | 17.76 |
| EV / EBIT | 22.02 |
| EV / FCF | 14.93 |
Financial Position
The company has a current ratio of 5.76, with a Debt / Equity ratio of 0.21.
| Current Ratio | 5.76 |
| Quick Ratio | 5.02 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | 0.77 |
| Debt / FCF | 0.65 |
| Interest Coverage | 18.31 |
Financial Efficiency
Return on equity (ROE) is 20.65% and return on invested capital (ROIC) is 11.02%.
| Return on Equity (ROE) | 20.65% |
| Return on Assets (ROA) | 9.41% |
| Return on Invested Capital (ROIC) | 11.02% |
| Return on Capital Employed (ROCE) | 17.97% |
| Revenue Per Employee | $2.04M |
| Profits Per Employee | $598,746 |
| Employee Count | 130 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 1.26 |
Taxes
In the past 12 months, AUPH has paid $1.80 million in taxes.
| Income Tax | 1.80M |
| Effective Tax Rate | 2.26% |
Stock Price Statistics
The stock price has increased by +79.13% in the last 52 weeks. The beta is 1.44, so AUPH's price volatility has been higher than the market average.
| Beta (5Y) | 1.44 |
| 52-Week Price Change | +79.13% |
| 50-Day Moving Average | 13.44 |
| 200-Day Moving Average | 10.27 |
| Relative Strength Index (RSI) | 58.34 |
| Average Volume (20 Days) | 1,821,657 |
Short Selling Information
The latest short interest is 8.53 million, so 6.47% of the outstanding shares have been sold short.
| Short Interest | 8.53M |
| Short Previous Month | 8.32M |
| Short % of Shares Out | 6.47% |
| Short % of Float | 6.65% |
| Short Ratio (days to cover) | 4.72 |
Income Statement
In the last 12 months, AUPH had revenue of $265.81 million and earned $77.84 million in profits. Earnings per share was $0.55.
| Revenue | 265.81M |
| Gross Profit | 213.08M |
| Operating Income | 81.10M |
| Pretax Income | 79.64M |
| Net Income | 77.84M |
| EBITDA | 100.55M |
| EBIT | 81.10M |
| Earnings Per Share (EPS) | $0.55 |
Balance Sheet
The company has $351.51 million in cash and $78.21 million in debt, giving a net cash position of $273.30 million or $2.07 per share.
| Cash & Cash Equivalents | 351.51M |
| Total Debt | 78.21M |
| Net Cash | 273.30M |
| Net Cash Per Share | $2.07 |
| Equity (Book Value) | 365.77M |
| Book Value Per Share | 2.77 |
| Working Capital | 362.52M |
Cash Flow
In the last 12 months, operating cash flow was $120.10 million and capital expenditures -$461,000, giving a free cash flow of $119.64 million.
| Operating Cash Flow | 120.10M |
| Capital Expenditures | -461,000 |
| Free Cash Flow | 119.64M |
| FCF Per Share | $0.91 |
Margins
Gross margin is 80.16%, with operating and profit margins of 30.51% and 29.28%.
| Gross Margin | 80.16% |
| Operating Margin | 30.51% |
| Pretax Margin | 29.96% |
| Profit Margin | 29.28% |
| EBITDA Margin | 37.83% |
| EBIT Margin | 30.51% |
| FCF Margin | 45.01% |
Dividends & Yields
AUPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.24% |
| Shareholder Yield | 1.24% |
| Earnings Yield | 3.78% |
| FCF Yield | 5.81% |
Analyst Forecast
The average price target for AUPH is $17.25, which is 10.44% higher than the current price. The consensus rating is "Buy".
| Price Target | $17.25 |
| Price Target Difference | 10.44% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 14.38% |
| EPS Growth Forecast (5Y) | 84.71% |
Stock Splits
The last stock split was on October 23, 2013. It was a reverse split with a ratio of 1:50.
| Last Split Date | Oct 23, 2013 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
AUPH has an Altman Z-Score of 4.05 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.05 |
| Piotroski F-Score | 6 |